vs
Enhabit, Inc.（EHAB）与通用电气医疗（OPCH）财务数据对比。点击上方公司名可切换其他公司
通用电气医疗的季度营收约是Enhabit, Inc.的5.3倍（$1.4B vs $270.4M）。通用电气医疗净利率更高（3.6% vs -14.3%，领先17.9%）。通用电气医疗同比增速更快（12.2% vs 4.7%）。通用电气医疗自由现金流更多（$130.2M vs $3.3M）。过去两年通用电气医疗的营收复合增速更高（13.0% vs 1.5%）
Enhabit, Inc.是总部位于美国得克萨斯州达拉斯的居家护理与临终关怀服务提供商，目前在全美34个州运营255个居家护理站点与110个临终关怀站点，业务集中在得克萨斯、亚拉巴马、佛罗里达、佐治亚、俄克拉荷马与密西西比，是美国第四大居家护理服务商，也是头部临终关怀服务商，2022年由恩compass健康拆分居家护理与临终关怀业务拆分成立。
通用电气医疗是总部位于美国伊利诺伊州芝加哥的医疗科技企业，旗下设四大业务板块：医学影像（含分子成像、CT、磁共振、女性健康筛查及X线设备）、超声、患者护理解决方案（覆盖远程患者监测、麻醉呼吸护理、心脏病诊断、婴儿护理等）及制药相关业务。
EHAB vs OPCH — 直观对比
营收规模更大
OPCH
是对方的5.3倍
$270.4M
营收增速更快
OPCH
高出7.5%
4.7%
净利率更高
OPCH
高出17.9%
-14.3%
自由现金流更多
OPCH
多$126.9M
$3.3M
两年增速更快
OPCH
近两年复合增速
1.5%
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $270.4M | $1.4B |
| 净利润 | $-38.7M | $51.8M |
| 毛利率 | — | 19.0% |
| 营业利润率 | -12.3% | 5.9% |
| 净利率 | -14.3% | 3.6% |
| 营收同比 | 4.7% | 12.2% |
| 净利润同比 | 15.9% | -3.8% |
| 每股收益（稀释后） | $-0.76 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHABOPCH
| Q4 25 | $270.4M | — | ||
| Q3 25 | $263.6M | $1.4B | ||
| Q2 25 | $266.1M | $1.4B | ||
| Q1 25 | $259.9M | $1.3B | ||
| Q4 24 | $258.2M | $1.3B | ||
| Q3 24 | $253.6M | $1.3B | ||
| Q2 24 | $260.6M | $1.2B | ||
| Q1 24 | $262.4M | $1.1B |
净利润EHABOPCH
| Q4 25 | $-38.7M | — | ||
| Q3 25 | $11.1M | $51.8M | ||
| Q2 25 | $5.2M | $50.5M | ||
| Q1 25 | $17.8M | $46.7M | ||
| Q4 24 | $-46.0M | $60.1M | ||
| Q3 24 | $-110.2M | $53.9M | ||
| Q2 24 | $-200.0K | $53.0M | ||
| Q1 24 | $200.0K | $44.8M |
毛利率EHABOPCH
| Q4 25 | — | — | ||
| Q3 25 | — | 19.0% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 21.3% | ||
| Q3 24 | — | 20.1% | ||
| Q2 24 | — | 20.3% | ||
| Q1 24 | — | 20.8% |
营业利润率EHABOPCH
| Q4 25 | -12.3% | — | ||
| Q3 25 | 6.4% | 5.9% | ||
| Q2 25 | 6.3% | 5.8% | ||
| Q1 25 | 6.1% | 5.9% | ||
| Q4 24 | -16.0% | 6.9% | ||
| Q3 24 | -38.6% | 6.7% | ||
| Q2 24 | 4.3% | 6.6% | ||
| Q1 24 | 4.9% | 6.0% |
净利率EHABOPCH
| Q4 25 | -14.3% | — | ||
| Q3 25 | 4.2% | 3.6% | ||
| Q2 25 | 2.0% | 3.6% | ||
| Q1 25 | 6.8% | 3.5% | ||
| Q4 24 | -17.8% | 4.8% | ||
| Q3 24 | -43.5% | 4.2% | ||
| Q2 24 | -0.1% | 4.3% | ||
| Q1 24 | 0.1% | 3.9% |
每股收益（稀释后）EHABOPCH
| Q4 25 | $-0.76 | — | ||
| Q3 25 | $0.22 | $0.32 | ||
| Q2 25 | $0.10 | $0.31 | ||
| Q1 25 | $0.35 | $0.28 | ||
| Q4 24 | $-0.92 | $0.36 | ||
| Q3 24 | $-2.20 | $0.31 | ||
| Q2 24 | $0.00 | $0.30 | ||
| Q1 24 | $0.01 | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $43.6M | $309.8M |
| 总债务越低越好 | $426.0M | $1.2B |
| 股东权益账面价值 | $534.0M | $1.4B |
| 总资产 | $1.2B | $3.5B |
| 负债/权益比越低杠杆越低 | 0.80× | 0.86× |
8季度趋势，按日历期对齐
现金及短期投资EHABOPCH
| Q4 25 | $43.6M | — | ||
| Q3 25 | $56.9M | $309.8M | ||
| Q2 25 | $37.1M | $198.8M | ||
| Q1 25 | $39.5M | $171.4M | ||
| Q4 24 | $28.4M | $412.6M | ||
| Q3 24 | $45.7M | $483.0M | ||
| Q2 24 | $28.5M | $376.9M | ||
| Q1 24 | $36.5M | $219.5M |
总债务EHABOPCH
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | $1.2B | ||
| Q2 25 | $456.9M | $1.1B | ||
| Q1 25 | $467.3M | $1.1B | ||
| Q4 24 | $492.6M | $1.1B | ||
| Q3 24 | $502.9M | $1.1B | ||
| Q2 24 | $512.7M | $1.1B | ||
| Q1 24 | $526.7M | $1.1B |
股东权益EHABOPCH
| Q4 25 | $534.0M | — | ||
| Q3 25 | $566.8M | $1.4B | ||
| Q2 25 | $552.4M | $1.4B | ||
| Q1 25 | $543.2M | $1.4B | ||
| Q4 24 | $523.5M | $1.4B | ||
| Q3 24 | $566.1M | $1.4B | ||
| Q2 24 | $674.3M | $1.4B | ||
| Q1 24 | $672.3M | $1.4B |
总资产EHABOPCH
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $3.5B | ||
| Q2 25 | $1.2B | $3.4B | ||
| Q1 25 | $1.2B | $3.3B | ||
| Q4 24 | $1.2B | $3.4B | ||
| Q3 24 | $1.3B | $3.4B | ||
| Q2 24 | $1.4B | $3.3B | ||
| Q1 24 | $1.4B | $3.2B |
负债/权益比EHABOPCH
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | 0.86× | ||
| Q2 25 | 0.83× | 0.82× | ||
| Q1 25 | 0.86× | 0.82× | ||
| Q4 24 | 0.94× | 0.79× | ||
| Q3 24 | 0.89× | 0.78× | ||
| Q2 24 | 0.76× | 0.79× | ||
| Q1 24 | 0.78× | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.4M | $139.4M |
| 自由现金流经营现金流 - 资本支出 | $3.3M | $130.2M |
| 自由现金流率自由现金流/营收 | 1.2% | 9.1% |
| 资本支出强度资本支出/营收 | 0.4% | 0.6% |
| 现金转化率经营现金流/净利润 | — | 2.69× |
| 过去12个月自由现金流最近4个季度 | $65.8M | $220.7M |
8季度趋势，按日历期对齐
经营现金流EHABOPCH
| Q4 25 | $4.4M | — | ||
| Q3 25 | $37.8M | $139.4M | ||
| Q2 25 | $10.6M | $90.3M | ||
| Q1 25 | $17.9M | $-7.2M | ||
| Q4 24 | $-4.1M | $36.1M | ||
| Q3 24 | $28.4M | $160.4M | ||
| Q2 24 | $9.6M | $195.7M | ||
| Q1 24 | $17.3M | $-68.8M |
自由现金流EHABOPCH
| Q4 25 | $3.3M | — | ||
| Q3 25 | $36.2M | $130.2M | ||
| Q2 25 | $8.7M | $81.2M | ||
| Q1 25 | $17.6M | $-16.6M | ||
| Q4 24 | $-4.7M | $25.8M | ||
| Q3 24 | $27.7M | $150.7M | ||
| Q2 24 | $8.9M | $185.9M | ||
| Q1 24 | $15.5M | $-74.6M |
自由现金流率EHABOPCH
| Q4 25 | 1.2% | — | ||
| Q3 25 | 13.7% | 9.1% | ||
| Q2 25 | 3.3% | 5.7% | ||
| Q1 25 | 6.8% | -1.2% | ||
| Q4 24 | -1.8% | 2.0% | ||
| Q3 24 | 10.9% | 11.8% | ||
| Q2 24 | 3.4% | 15.1% | ||
| Q1 24 | 5.9% | -6.5% |
资本支出强度EHABOPCH
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.6% | 0.6% | ||
| Q2 25 | 0.7% | 0.6% | ||
| Q1 25 | 0.1% | 0.7% | ||
| Q4 24 | 0.2% | 0.8% | ||
| Q3 24 | 0.3% | 0.8% | ||
| Q2 24 | 0.3% | 0.8% | ||
| Q1 24 | 0.7% | 0.5% |
现金转化率EHABOPCH
| Q4 25 | — | — | ||
| Q3 25 | 3.41× | 2.69× | ||
| Q2 25 | 2.04× | 1.79× | ||
| Q1 25 | 1.01× | -0.15× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 2.98× | ||
| Q2 24 | — | 3.69× | ||
| Q1 24 | 86.50× | -1.54× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
OPCH
| Commercial Customer | $1.3B | 87% |
| Government Customer | $172.8M | 12% |
| Patient Customer | $10.1M | 1% |
| Corporate Joint Venture | $1.9M | 0% |
